Logo image of HLNE

HAMILTON LANE INC-CLASS A (HLNE) Stock Fundamental Analysis

NASDAQ:HLNE - Nasdaq - US4074971064 - Common Stock - Currency: USD

149.83  -1.55 (-1.02%)

Fundamental Rating

6

HLNE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 233 industry peers in the Capital Markets industry. While HLNE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. HLNE is valued quite expensive, but it does show an excellent growth. These ratings could make HLNE a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year HLNE was profitable.
In the past year HLNE had a positive cash flow from operations.
HLNE had positive earnings in each of the past 5 years.
Each year in the past 5 years HLNE had a positive operating cash flow.
HLNE Yearly Net Income VS EBIT VS OCF VS FCFHLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 12.86%, HLNE belongs to the top of the industry, outperforming 93.56% of the companies in the same industry.
The Return On Equity of HLNE (30.31%) is better than 94.42% of its industry peers.
HLNE's Return On Invested Capital of 20.84% is amongst the best of the industry. HLNE outperforms 97.85% of its industry peers.
HLNE had an Average Return On Invested Capital over the past 3 years of 22.58%. This is significantly above the industry average of 7.86%.
Industry RankSector Rank
ROA 12.86%
ROE 30.31%
ROIC 20.84%
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
HLNE Yearly ROA, ROE, ROICHLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

1.3 Margins

Looking at the Profit Margin, with a value of 30.49%, HLNE is in the better half of the industry, outperforming 76.39% of the companies in the same industry.
In the last couple of years the Profit Margin of HLNE has grown nicely.
HLNE's Operating Margin of 44.40% is fine compared to the rest of the industry. HLNE outperforms 75.97% of its industry peers.
HLNE's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 44.4%
PM (TTM) 30.49%
GM N/A
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
HLNE Yearly Profit, Operating, Gross MarginsHLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, HLNE has more shares outstanding
HLNE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for HLNE is higher compared to a year ago.
HLNE Yearly Shares OutstandingHLNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
HLNE Yearly Total Debt VS Total AssetsHLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

HLNE has an Altman-Z score of 6.46. This indicates that HLNE is financially healthy and has little risk of bankruptcy at the moment.
HLNE's Altman-Z score of 6.46 is amongst the best of the industry. HLNE outperforms 87.12% of its industry peers.
The Debt to FCF ratio of HLNE is 1.01, which is an excellent value as it means it would take HLNE, only 1.01 years of fcf income to pay off all of its debts.
HLNE has a better Debt to FCF ratio (1.01) than 88.41% of its industry peers.
HLNE has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.40, HLNE is doing good in the industry, outperforming 71.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 1.01
Altman-Z 6.46
ROIC/WACCN/A
WACCN/A
HLNE Yearly LT Debt VS Equity VS FCFHLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.16 indicates that HLNE should not have too much problems paying its short term obligations.
HLNE has a Current ratio (1.16) which is comparable to the rest of the industry.
HLNE has a Quick Ratio of 1.16. This is a normal value and indicates that HLNE is financially healthy and should not expect problems in meeting its short term obligations.
HLNE's Quick ratio of 1.16 is in line compared to the rest of the industry. HLNE outperforms 52.36% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
HLNE Yearly Current Assets VS Current LiabilitesHLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.57% over the past year.
HLNE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.18% yearly.
The Revenue has grown by 28.73% in the past year. This is a very strong growth!
HLNE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.08% yearly.
EPS 1Y (TTM)28.57%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%-12.32%
Revenue 1Y (TTM)28.73%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%12.06%

3.2 Future

The Earnings Per Share is expected to grow by 9.54% on average over the next years. This is quite good.
HLNE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.19% yearly.
EPS Next Y-9.41%
EPS Next 2Y6.36%
EPS Next 3Y9.54%
EPS Next 5YN/A
Revenue Next Year2.26%
Revenue Next 2Y10.01%
Revenue Next 3Y13.19%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HLNE Yearly Revenue VS EstimatesHLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
HLNE Yearly EPS VS EstimatesHLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 29.73, the valuation of HLNE can be described as expensive.
69.53% of the companies in the same industry are cheaper than HLNE, based on the Price/Earnings ratio.
HLNE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.41.
HLNE is valuated quite expensively with a Price/Forward Earnings ratio of 32.82.
Based on the Price/Forward Earnings ratio, HLNE is valued a bit more expensive than 72.10% of the companies in the same industry.
HLNE is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 35.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 29.73
Fwd PE 32.82
HLNE Price Earnings VS Forward Price EarningsHLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HLNE is valued a bit cheaper than the industry average as 66.52% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HLNE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 27.79
EV/EBITDA 24.92
HLNE Per share dataHLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

HLNE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.47
EPS Next 2Y6.36%
EPS Next 3Y9.54%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.41%, HLNE has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 7.77, HLNE is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.35, HLNE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.41%

5.2 History

The dividend of HLNE is nicely growing with an annual growth rate of 19.56%!
HLNE has been paying a dividend for over 5 years, so it has already some track record.
HLNE has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)19.56%
Div Incr Years7
Div Non Decr Years7
HLNE Yearly Dividends per shareHLNE Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

34.95% of the earnings are spent on dividend by HLNE. This is a low number and sustainable payout ratio.
HLNE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP34.95%
EPS Next 2Y6.36%
EPS Next 3Y9.54%
HLNE Yearly Income VS Free CF VS DividendHLNE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
HLNE Dividend Payout.HLNE Dividend Payout, showing the Payout Ratio.HLNE Dividend Payout.PayoutRetained Earnings

HAMILTON LANE INC-CLASS A

NASDAQ:HLNE (7/14/2025, 12:38:25 PM)

149.83

-1.55 (-1.02%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-29 2025-05-29/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners109.79%
Inst Owner Change0%
Ins Owners4.67%
Ins Owner Change-3.15%
Market Cap8.02B
Analysts50
Price Target159.8 (6.65%)
Short Float %6.9%
Short Ratio3.87
Dividend
Industry RankSector Rank
Dividend Yield 1.41%
Yearly Dividend1.38
Dividend Growth(5Y)19.56%
DP34.95%
Div Incr Years7
Div Non Decr Years7
Ex-Date06-20 2025-06-20 (0.54)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.33%
Min EPS beat(2)1.1%
Max EPS beat(2)11.55%
EPS beat(4)3
Avg EPS beat(4)11%
Min EPS beat(4)-3.63%
Max EPS beat(4)34.99%
EPS beat(8)5
Avg EPS beat(8)6.73%
EPS beat(12)8
Avg EPS beat(12)8.94%
EPS beat(16)12
Avg EPS beat(16)12.74%
Revenue beat(2)2
Avg Revenue beat(2)9.07%
Min Revenue beat(2)4.44%
Max Revenue beat(2)13.69%
Revenue beat(4)3
Avg Revenue beat(4)10.27%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)26.31%
Revenue beat(8)5
Avg Revenue beat(8)8.43%
Revenue beat(12)7
Avg Revenue beat(12)11%
Revenue beat(16)8
Avg Revenue beat(16)7.79%
PT rev (1m)-0.74%
PT rev (3m)-6.75%
EPS NQ rev (1m)-1.82%
EPS NQ rev (3m)-17.91%
EPS NY rev (1m)-6.23%
EPS NY rev (3m)-13.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.71%
Revenue NY rev (1m)0.78%
Revenue NY rev (3m)-3.67%
Valuation
Industry RankSector Rank
PE 29.73
Fwd PE 32.82
P/S 11.25
P/FCF 27.79
P/OCF 26.67
P/B 11.19
P/tB 11.19
EV/EBITDA 24.92
EPS(TTM)5.04
EY3.36%
EPS(NY)4.57
Fwd EY3.05%
FCF(TTM)5.39
FCFY3.6%
OCF(TTM)5.62
OCFY3.75%
SpS13.31
BVpS13.39
TBVpS13.39
PEG (NY)N/A
PEG (5Y)1.47
Profitability
Industry RankSector Rank
ROA 12.86%
ROE 30.31%
ROCE 24.91%
ROIC 20.84%
ROICexc 26.65%
ROICexgc 27.46%
OM 44.4%
PM (TTM) 30.49%
GM N/A
FCFM 40.49%
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
ROICexc(3y)26.87%
ROICexc(5y)22.9%
ROICexgc(3y)28.19%
ROICexgc(5y)23.88%
ROCE(3y)26.99%
ROCE(5y)23.55%
ROICexcg growth 3Y19.01%
ROICexcg growth 5Y-5.25%
ROICexc growth 3Y19.07%
ROICexc growth 5Y-4.68%
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 1.01
Debt/EBITDA 0.89
Cap/Depr 130.92%
Cap/Sales 1.71%
Interest Coverage 30.44
Cash Conversion 92.32%
Profit Quality 132.77%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 6.46
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)109.9%
Cap/Depr(5y)192.46%
Cap/Sales(3y)1.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)135.75%
Profit Quality(5y)139.47%
High Growth Momentum
Growth
EPS 1Y (TTM)28.57%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%-12.32%
EPS Next Y-9.41%
EPS Next 2Y6.36%
EPS Next 3Y9.54%
EPS Next 5YN/A
Revenue 1Y (TTM)28.73%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%12.06%
Revenue Next Year2.26%
Revenue Next 2Y10.01%
Revenue Next 3Y13.19%
Revenue Next 5YN/A
EBIT growth 1Y28.8%
EBIT growth 3Y23.2%
EBIT growth 5Y22.13%
EBIT Next Year8.19%
EBIT Next 3Y16.93%
EBIT Next 5YN/A
FCF growth 1Y162.95%
FCF growth 3Y21.48%
FCF growth 5Y21.24%
OCF growth 1Y148.92%
OCF growth 3Y21.07%
OCF growth 5Y20.91%